I am an assistant attending physicist in the Department of Medical Physics. I have experience and interest in clinical physics, global health, and innovative research. I have a particular interest in developing low-cost solutions that can improve clinical procedures.
The main focuses of my research span two emerging areas of development. The first is data driven motion correction. This subfield seeks to correct the image degradation caused by inherent patient motion in nuclear imaging by using information contained in the raw acquisition data. This is an exciting area for study because it has the potential to be integrated into every PET image acquisition and provide potential clinical benefit, while imposing no changes to current imaging procedures. I have worked in this subfield for many years and helped to pioneer several of the concepts that are in wide use today.
My other area of research interest is in radionuclide dosimetry. Specifically, I am working to develop methodologies that will improve the workflow and accuracy of dosimetry operations in clinical environments. The aim of this work is to use improved metrology to improve patient treatments and care.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Adam Kesner discloses the following relationships and financial interests:
-
University of Colorado
Intellectual Property Rights
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures